Balyasny Asset Management LLC Macrogenics Inc Transaction History

Balyasny Asset Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$9.77 - $21.47 $195,888 - $430,473	20,050 Added 51.48%	58,997 $868,000
Q4 2023 Feb 14, 2024	BUY	$4.48 - $10.11 $124,073 - $279,996	27,695 Added 246.13%	38,947 $374,000
Q3 2023 Nov 14, 2023	SELL	$4.48 - $6.19 $106,668 - $147,383	-23,810 Reduced 67.91%	11,252 $52,000
Q2 2023 Aug 14, 2023	BUY	$4.62 - $7.54 $161,986 - $264,367	35,062 New	35,062 $187,000
Q4 2022 Feb 14, 2023	SELL	$3.34 - $6.98 $11,416 - $23,857	-3,418 Reduced 12.82%	23,244 $155,000
Q3 2022 Nov 14, 2022	SELL	$3.01 - $5.22 $25,094 - $43,519	-8,337 Reduced 23.82%	26,662 $92,000
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $78,747 - $349,640	34,999 New	34,999 $103,000
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $2.62 Million - $4.56 Million	-127,866 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$18.99 - $33.2 $2.43 Million - $4.25 Million	127,866 New	127,866 $4.07 Million
Q4 2020 Feb 16, 2021	SELL	$19.41 - $26.0 $1.54 Million - $2.07 Million	-79,563 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$24.69 - $31.6 $1.96 Million - $2.51 Million	79,563 New	79,563 $2 Million
Q3 2019 Nov 14, 2019	SELL	$12.44 - $17.48 $911,988 - $1.28 Million	-73,311 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$14.51 - $19.71 $1.06 Million - $1.44 Million	73,311 New	73,311 $1.24 Million
Q3 2018 Nov 14, 2018	SELL	$19.26 - $23.46 $380,808 - $463,851	-19,772 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$19.78 - $24.67 $391,090 - $487,775	19,772 New	19,772 $408,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.